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Association between blood glucose level and in-hospital
mortality in patients with acute myocardial infarctionDear Editor, Diabetes mellitus increases cardiovascular-
related morbidity and mortality and high blood glucose even
before it reaches the threshold to diagnose diabetes is asso-
ciated with higher cardiovascular risk.
Several studies previously reported that adverse cardiac
events increased in patients with acutemyocardial infarction.
However, the association between admission blood glucose
level and cardiac-related mortality and morbidity was not
studied in Iranian population.
Therefore, we conducted a study to assess the association
between on admission blood glucose level and in-hospital
cardiac mortality and prognosis in these patients.
The study designed prospectively and performed on
patients presenting to the emergency department of our
center with acute ST elevation myocardial infarction
(STEMI) between April, 2008 and April, 2010. STEMI was
diagnosed based on the acute rise and gradual fall of cardiac
enzymes with ischemic symptoms and ECG changes (ST
segment elevation or new left bundle branch block). Exclu-
sion criteria were severe co-morbidities, history of valvular
heart disease, and low ejection fraction before infarction
(EF<35%).
Demographic characteristics of all patients collected ini-
tially. Patientswere divided into four groups according to their
blood glucose levels (first group [G1]: <140 mg/dL; second
group [G2]: 140e199 mg/dL; third group [G3]: 200e249 mg/dL;
forth group [G4]: 250 mg/dL).
Primary endpoint of our study was in-hospital mortality.
Secondary endpoint defined as in-hospital cardiac and
non-cardiac morbidities included cardiogenic shock, atrio
ventricular block, left ventricular clot formation, and car-
diac arrhythmias. In-hospital non-cardiac morbidities were
defined as cerebrovascular events, renal failure, and gas-
trointestinal bleeding. Follow-up data were collected at
discharge or demise time. Out of 396 patients enrolled in
this study, 78% were male with mean age of 58  12. There
was significant increase in on-admission blood glucose
level when patients had history of diabetes mellitus or
smoking (p < 0.001).
Mortality in G1 group was lower compared to other groups
and G4 had highest mortality (p ¼ 0.001). Cardiac and non-
cardiac morbidities were 18% in G1 comparing to 22.8% in G4
which was not significant.The association between clinical characteristics of patients
and in-hospital mortality assessed withmultivariate analysis.
There was higher in-hospital mortality in female patient
group (p < 0.003; OR ¼ 2.56; CI 95%, 1.34e4.85) and hyper-
tensive patients (p < 0.002; OR ¼ 2.63; CI 95%, 1.39e4.99).
Patients received coronary intervention as treatment had
significantly lower mortality compare to patient received only
medical treatment. After binary logistic regression adjust-
ment for confounding variables only the blood glucose level
and age were still the independent predictor of in-hospital
mortality (p ¼ 0.002) and adjusted odds ratio for blood glu-
cose level was 1.56 (CI 95%, 1.18e2.07) in the forth quartile
compared with the first quartile.
Age as an independent predictor of in-hospital mortality
had adjusted odds ratio of 1.05 (CI 95%, 1.02e1.08) (p ¼ 0.001).
Cardiovascular mortality rate is out standing in developing
countries and age-relatedmortality rate of CADs is reached up
to 40% in Iran.1 There are limited data on CAD prevalence and
CAD risk factors in Middle East. Previous study proved that
diabetes is the most powerful risk factor for CAD.2 Hyper-
glycemia is associatedwith larger infarct size, lower LVEF, and
poor prognosis. Moreover, high glucose level has important
role in short- and long-term prognoses of AMI patients. The
present study shows that patients with STEMI and hyper-
glycemia on admission have a higher risk of in-hospital
mortality and this relation is independent of previous dia-
betes history.r e f e r e n c e s
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